These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 29269514)
1. 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis: Factor XI as a Target for New Anticoagulants. Weitz JI; Fredenburgh JC Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):304-310. PubMed ID: 29269514 [TBL] [Abstract][Full Text] [Related]
2. Factor XI and factor XII as targets for new anticoagulants. Weitz JI Thromb Res; 2016 May; 141 Suppl 2():S40-5. PubMed ID: 27207423 [TBL] [Abstract][Full Text] [Related]
3. Factor XI and contact activation as targets for antithrombotic therapy. Gailani D; Bane CE; Gruber A J Thromb Haemost; 2015 Aug; 13(8):1383-95. PubMed ID: 25976012 [TBL] [Abstract][Full Text] [Related]
4. Factor XI as a Therapeutic Target. Gailani D; Gruber A Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1316-22. PubMed ID: 27174099 [TBL] [Abstract][Full Text] [Related]
5. Factor XI as a target for antithrombotic therapy. Bane CE; Gailani D Drug Discov Today; 2014 Sep; 19(9):1454-8. PubMed ID: 24886766 [TBL] [Abstract][Full Text] [Related]
6. Factor XI and coagulation. Factor XI inhibitors - antithrombotic perspectives. Vlădăreanu AM; Roşca A Rom J Intern Med; 2024 Jun; 62(2):91-100. PubMed ID: 38153875 [TBL] [Abstract][Full Text] [Related]
7. Factors IX, XI, and XII: potential therapeutic targets for anticoagulant therapy in atherothrombosis. Rai V; Balters MW; Agrawal DK Rev Cardiovasc Med; 2019 Dec; 20(4):245-253. PubMed ID: 31912715 [TBL] [Abstract][Full Text] [Related]
8. Factor XI antisense oligonucleotide for prevention of venous thrombosis. Büller HR; Bethune C; Bhanot S; Gailani D; Monia BP; Raskob GE; Segers A; Verhamme P; Weitz JI; N Engl J Med; 2015 Jan; 372(3):232-40. PubMed ID: 25482425 [TBL] [Abstract][Full Text] [Related]
9. Factor XI as a Target for New Anticoagulants. Fredenburgh JC; Weitz JI Hamostaseologie; 2021 Apr; 41(2):104-110. PubMed ID: 33860518 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway? van Montfoort ML; Meijers JC Thromb Haemost; 2013 Aug; 110(2):223-32. PubMed ID: 23739841 [TBL] [Abstract][Full Text] [Related]
11. Factor XI inhibition fulfilling the optimal expectations for ideal anticoagulation. Székely O; Borgi M; Lip GYH Expert Opin Emerg Drugs; 2019 Mar; 24(1):55-61. PubMed ID: 30845846 [TBL] [Abstract][Full Text] [Related]
12. Coagulation factor XI as a novel target for antithrombotic treatment. Löwenberg EC; Meijers JC; Monia BP; Levi M J Thromb Haemost; 2010 Nov; 8(11):2349-57. PubMed ID: 20727068 [TBL] [Abstract][Full Text] [Related]
13. Factor XI and XII as antithrombotic targets. Müller F; Gailani D; Renné T Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835 [TBL] [Abstract][Full Text] [Related]
14. Intrinsic pathway of coagulation and arterial thrombosis. Gailani D; Renné T Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770 [TBL] [Abstract][Full Text] [Related]
15. The hemostatic role of factor XI. Puy C; Rigg RA; McCarty OJ Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433 [TBL] [Abstract][Full Text] [Related]
16. Upstream versus downstream thrombin inhibition. Gulpen AJ; Ten Cate-Hoek AJ; Ten Cate H Expert Rev Cardiovasc Ther; 2016 Nov; 14(11):1273-1282. PubMed ID: 27575701 [TBL] [Abstract][Full Text] [Related]
17. [Thrombosis and cancer. An update of our knowledge]. Tumori; 2006; 92(5):23-41. PubMed ID: 17168451 [No Abstract] [Full Text] [Related]
19. Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk. Zhang H; Löwenberg EC; Crosby JR; MacLeod AR; Zhao C; Gao D; Black C; Revenko AS; Meijers JC; Stroes ES; Levi M; Monia BP Blood; 2010 Nov; 116(22):4684-92. PubMed ID: 20807891 [TBL] [Abstract][Full Text] [Related]
20. New anticoagulants: Moving beyond the direct oral anticoagulants. Fredenburgh JC; Weitz JI J Thromb Haemost; 2021 Jan; 19(1):20-29. PubMed ID: 33047462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]